An ex-Vant fur­ther im­mers­es it­self in a new um­brel­la, cash­ing out in a $584M M&A deal with Sum­it­o­mo Dainip­pon sub­sidiary

A for­mer Vivek Ra­maswamy biotech is be­ing brought clos­er in­to its new own­er’s fam­i­ly of com­pa­nies.

Sum­i­to­vant, the um­brel­la sub­sidiary of Sum­it­o­mo Dainip­pon that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER